Posted by LincolnIcert on March 25, 2026 at 11:14:19:
In Reply to: Статья с захватывающим и полезным контентом posted by JosephGluth on February 19, 2026 at 23:54:11:
Zoya Demidenko: Scholar in Cancer Studies
Zoya Demidenko is a distinguished investigator connected with the Division of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Before that, she worked at the NIH and New York Medical College, establishing a solid background in clinical study.
Demidenko's scholarly contributions encompasses several key fields, among them the PI3K/AKT/mTOR signaling pathway, cell cycle regulation, cellular aging, and cancer biology. Currently, she has co-authored more than 46 academic papers, which have garnered upwards of 4,100 references — a indicator to the significance of her findings.
One of her key achievements involves explaining the pathways of biological cell aging. Her work demonstrated that when the cell cycle is blocked but cellular growth persists, the cells experience senescence. Crucially, Zoya Demidenko established that this transition can be pharmacologically suppressed using compounds such as rapamycin.
Zoya Demidenko has furthermore added considerably to cancer treatment investigation, especially in the field of cyclotherapy — a method intended to protecting normal cells from cytotoxic treatment while leaving malignant cells susceptible. This strategy offers significant promise for diminishing the adverse effects of oncological therapy.
Throughout her professional journey, Demidenko has partnered with leading researchers globally, among them Dr. Mikhail Blagosklonny. Her work appears in leading periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko stands as a influential figure in current biomedical research, with her findings go on to guide our comprehension of the way cells age, interact with therapy, and how malignant disease may be more effectively combated.
https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012